Nanoparticles: A smart drug delivery
In recent years, there has been an exponential interest in the development of novel drug delivery systems using nanoparticles. Nanoparticles are defined as particulate dispersions or solid particles with size in the range of 10-1000nm. There has been a considerable research interest in the area of drug delivery using particulate delivery systems as carriers for small and large molecules. Particulate systems like nanoparticles have been used as a physical approach to alter and improve the pharmacokinetic and pharmacodynamic properties of various types of drug molecules. Nanoparticles have been extensively studied as particulate carriers in the pharmaceutical and medical fields, because they show promise as drug delivery systems as a result of their sustained and targeting release properties, subcellular size, biocompatibility with tissue and cells. Various polymers have been used in the formulation of nanoparticles for targeting drug delivery research to increase therapeutic benefit, while minimizing side effects. Polymeric nanoparticls with a size in the nanometer range protect drugs against in vitro and in vivo degradation. The use of nanoparticle drug delivery is a universal approach to increase the therapeutic performance of poorly soluble drugs in any route of administration. In this review focused various aspects of nanoparticle formulation, characterization and their applications in targeting delivery.
Keywords: Nanoparticles, Drug Targeting and Controlled Release.
2. Tamizhrasi S, Shukla A, Shivkumar T, Rathi V, Rathi J C. Formulation and evaluation of Lamivudine loaded polymethacrylic acid nanoparticles. Int. J. Pharm. Tech. Res. 2009; 1(3):411-415.
3. Mandal B. Preparation and physicochemical characterization of eudragit®RL100 Nanosuspension with potential for ocular delivery of Sulfacetamide. J. Pharm. Sciences. 2010; 13(4):500-523.
4. Samuli, H. Preparation and characterization of poly (lactic acid) nanoparticles for pharmaceutical use. Int. J. Pharmacy. 2008; 15:1-30.
5. Carlos E.A. Synthesis of poly (dl-lactide-co-glycolide) nanoparticles with entrapped magnetite. Catholic Louisiana state university of Chile. 2005; 1(1):1-85.
6. Sailaja A.K, Amareshwar P, Chakravarty, P. Different techniques used for the preparation of nanoparticles using natural polymers and their application. Int. J. Pharm. Pharm. Sci. 2011; 3(2):45-50.
7. Wang J J, Zeng Z W, Xiao, R.Z Xie T, Zhou G L, Zhan X R, Wang S L. Recent advances of chitosan nanoparticles as drug carriers.,Int. J. Nanomedicine. 2011; 6:765-774.
8. Reis C.P., Neufeld J.R., Ribeiro A.J., Veiga F. Nanoencapsulation methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine: Nanotech. Bio. Med. 2006; 2:8-21.
9. Arias J.L. Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems. Molecules. 2008; 13:2340-2369.
10. Sanyogitta P. Novel functionalized polymers for nanoparticle formulations with anti cancer drugs. University of Nottingham. 2007; 1-200.
11. Soppimatha, K.S, Aminabhavia, T.M, Kulkarnia, A.R, Rudzinski, W.E (2001). Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Rel. 2001; 70:1-20.
12. Mohanraj V.J, Chen Y. Nanoparticles –a review. J. Pharm. Res. 2006; 5(1):561-573.
13. Sivabalan M, Shering, A, Reddy, P, Vasudevaiah, Jose, A, Nigila, G. Formulation and evaluation of 5-Fluorouracil loaded Chitosan and Eudragit® nanoparticles for cancer therapy. Pharmacie Globale (IJCP). 2011; 2(1):1-4.
14. Salata O.V. Applications of nanoparticles in biology and medicine. J.nanobiotechnology. 2004; 2(3):1-6.
15. Bhosale U.V, Devi V.K. Preparation and in vitro evaluation of Acyclovir loaded Eudragit RLPO nanoparticles as sustained release carriers. RGUHS J. Pharm. Sci. 2011; 1(1):85-92.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).